Skip to main content
. 2016 Jan 27;10:81–98. doi: 10.2147/PPA.S93726

Table 1.

Baseline variables

Variable type Variable Range n (%) Mean (SD)
Sociodemographic Age, years (n=191) 23–75 53.8 (11.2)
Education (n=191) Elementary 3 (1.6)
High school 62 (32.5)
College/trade school 94 (49.2)
More than college 32 (16.7)
Employment status (n=191) Employed full-time outside the home 40 (20.9)
Employed part-time outside the home 11 (5.8)
Employed full-time in the home 4 (2.1)
Employed part-time in the home 4 (2.1)
Retired 41 (21.5)
Unemployed 24 (12.6)
Other 67 (35.1)
Health literacy, (n=191) 3–15 13.1 (2.6)
Income, US$ (n=191) <10,000 26 (13.6)
10,000–20,000 24 (12.6)
>20,000–30,000 18 (9.4)
>30,000–50,000 31 (16.2)
>50,000–70,000 34 (17.8)
>70,000–90,000 23 (12.0)
>90,000 35 (18.3)
Primary insurance (n=190) Private 99 (52.1)
Medicare 37 (19.5)
Medicaid 24 (12.6)
Multiple 24 (12.6)
VA/other 6 (3.2)
Marital status (n=191) Married 103 (53.9)
Separated 14 (7.3)
Divorced 28 (14.7)
Widowed 8 (4.2)
Never married 38 (19.9)
Race (n=191) Black/African-American 79 (41.4)
White 112 (58.6)
Social support, (n=191) 0.17–9.00 3.7 (2.1)
Social support satisfaction (n=191) 1–6 (very dissatisfied–very satisfied) 5.6 (0.8)
Illness Cancer stage (n=191) I 20 (10.5)
II 28 (14.7)
III 34 (17.8)
IV 60 (31.4)
Unknown or unsure 49 (25.7)
Time since cancer diagnosis, months (n=191) 1–120 37.4 (35.8)
Charlson Comorbidity Index (n=191) 0–13 4.3 (2.7)
General health (n=191) Excellent 9 (4.7)
Very good 23 (12.0)
Good 58 (30.4)
Fair 68 (35.6)
Poor 33 (17.3)
Physical health not good, days within last 30 (n=191) 0–30 14.6 (10.7)
Mental health not good, days within last 30 (n=191) 0–30 9.6 (10.8)
Past history of substance abuse (n=191) No 157 (82.2)
Yes 34 (17.8)
Presence of chronic kidney disease (n=191) No 103 (53.9)
Yes 88 (46.1)
Presence of depression (n=191) No 110 (57.6)
Yes 81 (42.4)
Pain, function, and pain treatment Duration of cancer pain, months (n=175) 0–120 29.9 (31.0)
Worst pain in last week (n=191) 0–10 (no pain–pain as bad as you can imagine) 6.8 (2.4)
Average pain in last week (n=191) 0–10 (no pain–pain as bad as you can imagine) 4.9 (2.0)
Least pain in last week (n=191) 0–10 (no pain–pain as bad as you can imagine) 3.3 (1.9)
Pain-related functional interference score (n=191) 0–70 (does not interfere–completely interferes) 34.6 (15.8)
Pain relief with medications (n=191) 1–10 (10%–100%) 7.3 (2.0)
Hours pain medications effective (n=191) Does not help at all 1 (0.5)
1 6 (3.1)
2 15 (7.9)
3 27 (14.1)
4 48 (25.1)
5 82 (42.9)
>12 12 (6.3)
Pain Management Index (n=191) −2 4 (2.1)
−1 12 (6.3)
0 83 (43.5)
1 61 (14.7)
2 28 (14.7)
3 3 (1.6)
Total number of analgesics prescribed (n=191) 1 41 (21.5)
2 103 (54.9)
3 36 (18.9)
4 11 (5.8)
Total number of coanalgesics prescribed (n=191) 0 149 (78.0)
1 35 (18.3)
2 7 (3.7)
WHO analgesic step, index medication (n=191) Step 1 18 (9.4)
Step 2 20 (10.5)
Step 3 153 (80.1)
Prescription of long-acting opioids (n=191) No 82 (42.9)
Yes 109 (57.1)
How often prescribed medication taken per day (n=191) Not every day 2 (1.0)
1–2 times 71 (37.2)
3–4 times 81 (42.4)
5–6 times 29 (15.2)
>6 times 8 (4.2)
Number of analgesic side effects, MSEC (n=191) 0–8 3.9 (2.4)
Severity of side effects, MSEC (n=191) 8–80 (not severe–extremely severe) 25.5 (15.9)
Number of complementary alternative modalities used (n=191) 0–8 2.1 (1.7)
Analgesic attitudes and barriers CBC type of analgesic (n=191) ≤25% 155 (81.2)
>25% and ≤50% 17 (8.9)
>50% and ≤75% 19 (9.9)
CBC pain relief with analgesics (n=191) ≤25% 83 (43.5)
>25% and ≤50% 67 (35.1)
>50% and ≤75% 41 (21.5)
CBC type of side effects (n=191) ≤25% 145 (75.9)
>25% and ≤50% 43 (22.5)
>50% and ≤75% 3 (1.6)
CBC severity of side effects (n=191) ≤25% 132 (69.1)
>25% and ≤50% 41 (21.5)
>50% and ≤75% 18 (9.4)
CBC out-of-pocket cost of analgesics (n=191) ≤25% 180 (94.2)
>25% and ≤50% 10 (5.2)
>50% and ≤75% 1 (0.5)
Analgesic barriers, BQ-II (n=191) 0–96 66.2 (20.2)
BQ-II physiological effect severity (n=191) 0–51 30.6 (11.1)
BQ-II fatalism severity (n=191) 0–15 6.2 (3.5)
BQ-II communication severity (n=191) 0–28 11.3 (5.2)
BQ-II harmful effects severity (n=191) 0–30 18.1 (7.3)
Subjective adherence I sometimes forget to take my pain medicine, MMAS (n=191) No 127 (66.5)
Yes 64 (33.5)
I am sometimes careless about taking my pain medicine (n=191) No 158 (82.7)
Yes 33 (17.3)
When I feel better, I sometimes stop taking my pain medicine (n=191) No 104 (54.5)
Yes 87 (45.5)
If I feel worse when I take the pain medicine, sometimes I stop taking it (n=191) No 165 (86.4)
Yes 26 (13.6)

Abbreviations: BQ, Barriers Questionnaire; CBC, choice-based conjoint analysis; MMAS, Morisky Medication Adherence Scale; MSEC, Medication Side-Effects Checklist; SD, standard deviation; VA, Veterans Administration; WHO, World Health Organization.